The effect of varying Al2O3 percentage in hydroxyapatite/Al2O3 composite materials: morphological, chemical and cytotoxic evaluation.
Hydroxyapatite (HA) and HA-alumina (HA/Al2O3) composites, with Al2O3 contents of 5, 10, 20, and 30%, were synthesized using a wet precipitation method and sintered at 900 and 1300 degrees C. We investigated the effect of sintering temperature and relative concentration of HA and Al2O3 on the chemical composition, surface morphology, and cytotoxicity of the composite powders. The XRD results show that in the 1300 degrees C composites, HA partially decomposed into CaO which combined with Al2O3 to form different calcium aluminates. For the 900 degrees C composites the CaO phase was not detected, though a Ca/P ratio larger than 1.67 measured by XPS suggests that CaO was present in trace amounts. SEM-EDX analysis indicated that the HA microstructure was affected by the sintering temperature, and this HA is present on the surface of Al2O3 particles. The cytotoxicity of the composites was assessed indirectly using the MTT assay. The short-term effect of leachables was quantified by exposing a L929 mouse fibroblast cell line to the degradation products released by the composites after immersion in the cell culture medium. Degradation products were less toxic to L-929 at lower extract concentrations (10, 50%) than at 100% concentration. Cell viability was also influenced by leachable size.
Epure
L M
LM
Laboratoire d'Innovation et d'Analyse de Bioperformance-LIAB, Biomedical Engineering Institute, École Polytechnique de Montréal, Montréal, Québec, Canada.|Institut de cardiologie, Laboratoire de Pathologie Expérimentale, Université de Montréal, Montréal, Québec, Canada.
Dimitrievska
S
S
Laboratoire d'Innovation et d'Analyse de Bioperformance-LIAB, Biomedical Engineering Institute, École Polytechnique de Montréal, Montréal, Québec, Canada.|Institut de cardiologie, Laboratoire de Pathologie Expérimentale, Université de Montréal, Montréal, Québec, Canada.
Merhi
Y
Y
Institut de cardiologie, Laboratoire de Pathologie Expérimentale, Université de Montréal, Montréal, Québec, Canada.
Yahia
L 'h
L'
Laboratoire d'Innovation et d'Analyse de Bioperformance-LIAB, Biomedical Engineering Institute, École Polytechnique de Montréal, Montréal, Québec, Canada.
D000537:Aluminum Oxide / Q000737:chemistry* / Q000494:pharmacology; D000818:Animals; D002460:Cell Line; D017886:Durapatite / Q000737:chemistry* / Q000494:pharmacology; D051379:Mice; D008855:Microscopy, Electron, Scanning
D017886:Durapatite; D000537:Aluminum Oxide